Back
Canopy Growth Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
21
CGC
Canopy Growth
Last Price:
3.91
Seasonality Move:
9.94%
Buy
79
AUPH
Aurinia Pharmaceuticals
Last Price:
8.88
Seasonality Move:
24.51%
Sell
21
Canopy Growth (CGC)
is a Sell
Is Canopy Growth a Buy, Sell or Hold?
- The current Canopy Growth [CGC] share price is $3.90. The Score for CGC is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- CGC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
79
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $8.86. The Score for AUPH is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- AUPH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CGC Stock Price Chart
What is Canopy Growth's stock price today?
-
The Canopy Growth share price today is $3.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGC is experiencing selling pressure, which indicates risk of future bearish movement.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $8.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing slight buying pressure.
CGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 41.31 | Sell |
| Chaikin Money Flow: | -2280016 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.87 - 5.13) | Sell |
| Bollinger Bands (100): | (4.22 - 6.64) | Sell |
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 72.92 | Buy |
| Chaikin Money Flow: | 122744 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.17 - 8.37) | Buy |
| Bollinger Bands (100): | (5.81 - 7.63) | Buy |
CGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.82 | Buy |
| 20-day SMA: | 4.39 | Sell |
| 50-day SMA: | 4.48 | Sell |
| 200-day SMA: | 6.2 | Sell |
| 8-day EMA: | 3.91 | Sell |
| 20-day EMA: | 4.19 | Sell |
| 50-day EMA: | 4.61 | Sell |
| 200-day EMA: | 6.28 | Sell |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.34 | Buy |
| 20-day SMA: | 7.95 | Buy |
| 50-day SMA: | 7.43 | Buy |
| 200-day SMA: | 6.09 | Buy |
| 8-day EMA: | 8.41 | Buy |
| 20-day EMA: | 8.03 | Buy |
| 50-day EMA: | 7.49 | Buy |
| 200-day EMA: | 6.84 | Buy |
Canopy Growth Earnings Growth & CGC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.78 per share, and an increase next year of $0.05 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.54 per share.
Canopy Growth Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aurinia Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||